Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
about
MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibitionLung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.Targeting Novel but Less Common Driver Mutations and Chromosomal Translocations in Advanced Non-Small Cell Lung Cancer.A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review.Current Landscape of Targeted Therapy in Lung Cancer.Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance.The persistent promise of combining HGF/MET and EGFR inhibition in non-small cell lung cancer.Understanding and targeting resistance mechanisms in NSCLC.About MET expression and other biomarkers in non-small cell lung cancer.Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.[Progress of c-MET Signaling Pathway and TKIs in Non-small Cell Lung Cancer].Targeting MET in cancer therapy.Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials.MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer.An Update on Predictive Biomarkers for Treatment Selection in Non-Small Cell Lung Cancer.Identification of candidate genes or microRNAs associated with the lymph node metastasis of SCLC
P2860
Q36265149-AD85DD8B-A2C8-4F34-91FA-B177BCCBB219Q40070868-1A6BB68F-5DEF-4536-A2DA-F9E4235BE407Q42369856-4A4F63F0-B4A6-4395-8B40-9FEE469F759AQ42378367-7258968D-8A18-474B-BE0F-2B7DA11D0EF9Q45968290-2DD32FBC-490D-442A-90C2-D95B28669CBEQ46034707-E6DF6FDD-0DB7-4746-857E-A387FAB015CAQ46071509-3B5DE4A7-7A03-40B7-B037-FC9293F3FB76Q46073425-B483BA9E-6A5F-4471-AE45-727691B21609Q46915997-D8983AFD-BBA2-4FCA-BB18-1E8E9A5C1F51Q48142691-C83A2A66-7BBC-4F3C-9D9E-E56C52063A11Q52312436-688DEF26-246F-46F8-B1DE-EBEE918B801EQ53742581-BBA81BD9-A4A4-40D4-965C-08D2E57A1235Q54987450-E6291A4C-B8F9-4B01-A134-52E60D9DB2ECQ55191884-9FF4DB2A-01D2-4D69-9CE2-A1B5832F5536Q55347158-53056E5E-AE6C-45B9-B9B2-A37C6DE1E3A2Q55515425-6FBED685-1A70-4E29-95A0-B372A0E37741Q58586691-E27450FC-F13D-46EF-842F-8AB777EEE2CE
P2860
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
@en
type
label
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
@en
prefLabel
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
@en
P2093
P2860
P1476
Targeting MET in Lung Cancer: Will Expectations Finally Be MET?
@en
P2093
Alexander Drilon
D Ross Camidge
Federico Cappuzzo
P2860
P356
10.1016/J.JTHO.2016.10.014
P577
2016-10-26T00:00:00Z